Hot Investor Mandate: European VC Firm Establishes Dedicated Health Tech Fund to Invest Up to $10M in Promising Medical Devices, Diagnostics, and Digital Health Companies

31 Jan

A firm that has been actively investing for over 20 years with multiple offices in Europe has over €1 billion in total assets under management and recently closed its first dedicated Health Tech Fund, after successfully investing in the sector from mixed vehicles for more than 20 years. The firm typically invests €1-5 million in early-stage opportunities or up to €10 million in growth-stage opportunities. The firm is currently focused on companies based in Europe.

Within the life science sector, the firm is currently focused on medical technology, diagnostics, life science tools and platforms, and digital health across Europe. The firm is open to opportunities in any indication area and at any phase of development.

The firm is open to investing in companies at early stages with a proof-of-concept, clinically relevant data and/or strong IP positions.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: